InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+8.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Jackson Scott Thomas, Director. Officer active across 3 companies, notably Glycomimetics INC. Cumulatively, 8 disclosures have been published. History available since 18 May 2021. The latest transaction was disclosed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
10,000 sharesCommon StockSEC:0001193125-26-283202:0
6,500 sharesCommon StockSEC:0001125345-25-000083:0
20,000 shares0Common StockSEC:0000950170-24-066652:0
4,500 shares0Common StockSEC:0001125345-24-000107:0
20,000 shares0Common StockSEC:0000950170-23-052693:0
15,000 shares0Common StockSEC:0000899243-22-031505:0
5,250 shares0Common StockSEC:0001209191-21-036382
5,250 shares0Common StockSEC:0001209191-21-036382:0
8 of 8 declarations
About Jackson Scott Thomas
Scott Thomas Jackson is a Board Member at GlycoMimetics Inc. He contributes to the company's strategy and oversight of its activities. His experience in the biopharmaceutical sector is an asset to the board.
